Experiments have been performed to identify the type and size of cell infected by EB virus in the blood of acute infectious mononucleosis (IM) patients, and to investigate the nature of the infection. Virus-infected cells, recognized by their ability to give rise to lymphoblastoid cell lines when co-cultivated with foetal lymphocytes, were shown to be restricted to the B-lymphocyte population. Samples of this population from each of eight IM patients were found to be negative for EB nuclear antigen (EBNA) staining. Thereafter, fractions of IM B-lymphocytes prepared on the basis of cell size were assayed either by co-cultivation, for the incidence of virus-infected cells, or by immunofluorescence staining for the presence of cells expressing EBNA. The great majority of virus-infected cells were found in the fractions of normal sized B-lymphocytes and yet these fractions were unequivocally EBNA-negative. The finding of EB virus-infected, EBNA-negative B-cell populations in IM blood is discussed in terms of the type of infection established by EB virus in the circulation of IM patients.
INTRODUCTION
Paul-Bunnell positive infectious mononucleosis (IM) is a benign, self-limiting lymphoproliferative disease known to be caused by the Epstein-Barr (EB) virus (Henle, Henle & Diehl, I968) . EB virus-infected cells are clearly present in the blood of IM patients since leucocytes cultured from this source readily give rise to virus genome-eontaining cell lines of B-lymphocyte type (Pope, I967; Diehl et al. I968; Jondal & Klein, I973) . Since, in vitro, EB virus can confer on B-lymphocytes the ability to give continuous cell lines (Henle et al. I967; Pope, Home & Scott, I968; Pattengale, Smith & Gerber, I973) and in vivo is suspected of playing a causative role in two human malignancies, Burkitt's lymphoma and nasopharyngeal carcinoma (Epstein & Achong, I973b; Henle & Henle, I973; Klein, I975) , it has been widely assumed that the virus-infected cells in IM blood are potentially malignant B-lymphocytes transformed by the virus to be capable of direct outgrowth to give cell lines when placed in culture (see for instance Klein, .
Objections to this view (Epstein & Achong, I973 a) were supported by a series of experiments showing that IM-derived cell lines do not arise by direct outgrowth but by a quite different two-step process (Rickinson et al. I974, I975; Rickinson, Finerty & Epstein, I977) in which cells latently infected by the virus in vivo are activated to a cycle of virus production in vitro and release virus particles which then infect and transform B-lymphocytes coresident in the culture to give the permanent cell lines.
Thus, most of the virus-infected cells in IM blood do not appear to be transformed by the virus since there was no evidence of their independent in vitro outgrowth; however, the results did not exclude the possibility that a small minority of these cells might indeed be transformed and capable of direct growth in vitro, but that their contribution to the overall yield of proliferating cells in the cultures was so small that it had gone unnoticed (Rickinson et al. I974, I975) .
The present work was therefore undertaken to determine first of all which of the various sub-populations of leucocytes from IM blood was infected by EB virus in vivo, and thereafter, a search was made within this population for the presence of a small number of transformed cells capable of direct in vitro growth.
METHODS

Blood donors
IM patients. Heterophil antibody-positive IM patients from the general Bristol population were bled within 8 weeks of the onset of symptoms. Blood (50 ml) was taken by venepuncture into a heparinized syringe [20 international units (iu) heparin/ml]; a small volume of plasma from this blood was used for EB virus antibody studies. Ethical considerations prevented larger quantities of blood being taken from the patients.
Foetal-cord blood. Blood samples (2o to 50 ml) were taken from full term human placentae by venepuncture, and transferred into sterile, heparinized bottles (2o iu heparin/ml).
Cell counts. Total and differential leucocyte counts were done by standard methods. Medium. RPMI I64o medium supplemented with 2 mM-glutamine, Ioo iu/ml penicillin and 1oo #g/ml streptomycin was used for all washing procedures during the preparation of cell samples; 15 % foetal calf serum (FCS) was added to this medium for culturing purposes. Leibovitz LI5 medium containing phenol red indicator (3 ml/1) and supplemented with 2 mM-glutamine, 200 iu/ml penicillin, 200/zg/ml streptomycin and 20/0 FCS was used throughout the velocity sedimentation procedure.
Purification of cell types
(I) Platelets, granulocytes, mononuclear cells. Blood samples diluted I : 2withphosphatebuffered saline were centrifuged on a Ficoll-Triosil density gradient to obtain purified platelets (Pope, Scott & Moss, I973) and purified granulocytes and mononuclear cells (B6yum, 1968); the mononuclear cell population consisted of monocytes, T-lymphocytes and B-lymphocytes.
(2) T-lymphocytes, B-lymphoeytes with monocytes, purified B-lymphocytes. In some experiments T-lymphocytes were purified from the mononuclear cell population by allowing them to form E-rosettes with sheep erythrocytes (Wybran, Chantler & Fudenberg, I973) and then separating the rosetted and non-rosetted fractions by a second Ficoll-Triosil centrifugation (Greaves & Brown, i974) . Preparations of T-lymphocytes were obtained from the rosetted fraction by lysis of sheep erythrocytes in ammonium chloride solution (Jondal, I974a) , the preparations contained less than IO % surface immunoglobulin-positive cells as determined by immunofluorescence testing (Fr61and, Natvig & Berdal, I97I). The non-rosetted fraction provided preparations of B-lymphocytes with monocytes in which up to 95 % of the cells were surface immunoglubulin-positive; in further experiments, purified IP: 54.70.40.11
On: Thu, 20 Dec 2018 01:53:29 EB virus-infected EBNA-negative cells in IM 45I B-lymphocytes were prepared from this material by removing phagocytic cells (monocytes) with a magnet following incubation with carbonyl iron particles (Jondal, I974b ) (3) Adherent and non-adherent mononuclear cells. In other experiments the method of Pope et al. (I973) provided an adherent fraction, consisting of 85 to 95 % monocytes and 5 to I5~o lymphoid cells, and a non-adherent fraction containing 95 to Ioo% lymphoid cells.
Each purified cell fraction was washed twice and the cells were counted.
Cell separation by size using velocity sedimentation, The method adopted was essentially that described by Miller & Phillips (I969) as adapted for the separation of IM mononuclear cells by Denman & Pelton (I973, I974) . In order to ensure adequate separation, 5 x io v to 2 x IO 8 cells were loaded into the sedimentation chamber above a buffered step gradient of o'33% to 2% Ficoll in LI 5 medium; if the total number of cells to be separated was less than 5 x io v, washed sheep erythrocytes were used as a supplement in the initial loading of the chamber. Fractions (25 ml) were collected from the base of the chamber after 4 h sedimentation and numbered I to 22; since cells fall through the gradient at a rate proportional to the square of their radius, the largest cells appeared in the earliest fractions. The cells in each fraction were centrifuged to a pellet, resuspended in I ml medium and counted.
Assessment ofcellpopulations. To assess the homogeneity of the composition of the various cell populations, differential leucocyte counts were done on slide preparations in conjunction with size measurements made on photomicrographs.
Culturing techniques. Cells were cultured in 2 ml of medium in 1.5 cm diameter plastic vials (Sterilin, Richmond, Surrey) in a humidified atmosphere of 5 % CO2 in air. The cultures were re-fed every IO days by replacing half the medium without disturbing the cell layer, and were observed regularly over a period of at least IO weeks for signs of transformation. Transformation was recognized by the presence of foci of actively growing cells which continued to proliferate after sub-culturing.
Examination of chromosomes, Chromosome spreads were prepared from cultures containing transformed cells by methods already described (Jarvis et aL x974) and were stained with Giemsa.
The sex distribution within each cell population was determined by establishing the sex of between Io and 2o spreads from each culture.
Virus capsid antigen (VCA) staining. The EB virus-antibody status of the IM patients was determined by using their plasma samples in an indirect fluorescence test to detect antibodies to VCA (Henle & Henle, i966) .
EBNA staining. EBNA staining was performed as described by Reedman & Klein (I973) with the added complement reinforcement step suggested by Klein et al. (I976) . Duplicate slides of each cell preparation were stained using known anti-EBNA positive sera of high titre or known negative sera. On each occasion EBNA-positive Raji cells (Pulvertaft, I964) and EBNA-negative Ramos cells (Klein et aL I975) were included as controls. In addition, the sensitivity of the EBNA staining technique was assessed by including, as further controls, preparations made from mixtures of Raji and Ramos cells at ratios down to I : IOO, preparations made from foetal lymphocytes 2 days after their infection with EB virus in vitro, and preparations made from fractions obtained when mixtures of Raji cells and foetal lymphocytes were separated on the basis of cell size using the velocity sedimentation technique.
Experimental procedure. A first group of experiments was designed to identify EB virus-IP: 54.70.40.11
On: Thu, 20 Dec 2018 01:53:29 452 D.H. CRAWFORD AND OTHERS infected cells in leucocyte sub-populations prepared from IM blood. Virus-infected cells were detected by their ability to give rise to cell lines when co-cultivated with foetal cells. Mononuclear cells (4 x io6), granulocytes, B-lymphocytes with monocytes, or T-lymphocytes from IM blood were each co-cultivated with an equal number of foetal mononuclear cells of the opposite sex; the platelets from each IM patient were centrifuged into two equal pellets, each of which was likewise co-cultivated with 4 × lO6 foetal mononuclear cells. In separate experiments within this group, adherent and non-adherent cell fractions were prepared from lO 7 IM mononuclear cells, and each fraction was co-cultivated with 4 × lO6 foetal mononuclear cells in the same way. Cultures showing signs of transformation within the Io-week observation period were sub-cultured, and the transformed cells were submitted for chromosome analysis to determine their donor origin. Control cultures of foetal mononuclear cells alone were always included.
Since subsequent work involved experiments in which leucocytes were separated into fractions on the basis of size, a preliminary assessment of the quality of the size separation was next made. Cells in fractions separated by size from IM mononuclear cell populations or from B-lymphocytes with monocytes were counted and measured.
The experiments of the second group were designed to detect the presence of virusinfected cells in fractions of IM B-lymphocytes with monocytes separated by size. Each of 22 fractions was co-cultivated with 4 x i@ foetal mononuclear cells of the opposite sex, although in some cases consecutive fractions were pooled or subdivided, where necessary, to give around lO 6 IM-derived cells per co-culture. As before, cultures showing transformation during IO weeks of observation were sub-cultured and the transformed cells sexed to determine their donor origin. Foetal control cultures were likewise included.
In a third group of experiments the presence of EBNA-positive cells was sought in the circulating B-lymphocyte populations of a further set of IM donors. In each case, preparations for EBNA staining were made both from a sample of the purified B-lymphocyte population before fractionation and from the 22 fractions obtained when these cells were separated on the basis of size; consecutive fractions were pooled to give I to 2 x lO 6 cells per preparation, the pooled preparations being fractions I to 8, 9 and IO, I I and 12, 13 and 14, 15 and I6 and I7 to 22. Each preparation was examined after EBNA staining by three independent observers. In most experiments, the staining procedure was repeated on a second occasion using duplicate slides and a different pair of high titre EBNA-positive and control EBNA-negafive sera. Table I shows the time after onset of symptoms at which blood was taken from the IM patients, together with the results of the blood counts and EB VCA titrations in each case. It can be seen that the patients used for each group of experiments were strictly comparable by these criteria.
RESULTS
The results of the various experiments of the first group using blood samples from twelve IM patients are presented in Table 2 , which shows the overall incidence of transformation and the mean time to transformation for each type of co-culture set up. Transformed loci appeared after a mean time of 44 days in approximately half of those co-cultures containing all the IM mononuclear cells and, after a mean time of 34 days, in almost every one of those containing only B-lymphocytes with monocytes. In contrast, none of the co-cultures containing T-lymphocytes, granulocytes or platelets showed any signs of transformation. The results of three further experiments, in which the IM mononuclear cells were separated Table 2 Cells used in the 2nd groups of experiments -see Table 3 Cells used to assess separation technique -see Fig. I Cells used in the 3rd group of experiments -see Table 4 Cells used in the 4th group of experiments -for EBNA testing * All patients were VCA antibody-positive to a dilution of at least i/I6. t ND = Not done.
into adherent and non-adherent fractions before co-cultivation with foetal cells, are presented in Table 3 . Transformation was not seen in co-cultures containing the adherent fraction whereas transformed foci did appear in some co-cultures containing the nonadherent cells, although at a lower incidence than was seen in parallel co-cultures containing the corresponding total unfractionated IM mononuclear cell population.
In the experiments to assess the quality of fractions separated by size, it was found that fraction I contained cells with an average diameter of 2o #m, 80 % of which were atypical lymphocytes together with some eosinophils; this, and neighbouring large cell fractions included all the monocytes. In fraction IO, 9o % of the cells were medium sized lymphocytes with an average diameter of IO/zm, and in fraction 22 almost all the cells were very small lymphocytes with an average diameter of 7"5 #m. Figure I presents typical values for cell yields in each of the 22 size fractions obtained when either total mononuclear cells or Blymphocytes with monocytes were separated in this way. The total mononuclear cell popula- tion was fairly evenly distributed throughout fractions 3 to I6, whilst lower numbers of cells were present in the very first and the very last few fractions; the large atypical lymphocytes and the monocytes were found exclusively in fractions I to 8. When the total mononuclear cell population was first depleted of T-lymphocytes and the remaining B-lymphocytes with monocytes then separated by size, the cells were largely concentrated around a peak in fraction 13 and most of the large atypical cells were no longer present (Fig. I) . In this context it is important to note that when B-lymphocytes with monocytes from normal healthy donors were similarly fractionated by size, there was likewise a peak in fraction I3 made up of normal sized lymphocytes; as already mentioned, the relatively few monocytes were in both cases confined to the large cell fractions. The results of the second group of experiments, in which fractions prepared on the basis of cell size from the B-lymphocytes with monocytes from seven further IM donors were cocultivated with foetal cells, are presented in Table 4 . In one of the experiments, transformed foci appeared in almost every co-culture, while in the remaining six experiments transformation was restricted to co-cultures containing fractions 7 to ~8 and within that range was seen most regularly in co-cultures containing fractions I I to I4. Table 5 presents the pooled results of chromosome analyses of the transformed cells arising in co-cultures in these experiments and shows that the emergent cell lines were either exclusively of foetal origin or, more commonly, of mixed origin with foetal cells in predominance.
The results obtained from the third group of experiments involved another eight IM donors. In each case both the purified B-lymphocyte population and fractions of that population prepared on the basis of cell size were stained for EBNA, but no EBNApositive cells were seen despite intensive search. In contrast, isolated cells showing unequivocal EBNA staining could be detected in mixed populations of EBNA-positive Raji and EBNA-negative Ramos cells down to a ratio of I: Iooo; furthermore, the staining technique was readily able to detect large EBNA-positive blast cells forming 1% of the total population of foetal lymphocytes 2 days after infection with EB virus in vitro. As a final control, when mixtures of Raji cells and freshly prepared foetal lymphocytes were separated on the basis of cell size by velocity sedimentation, Raji cells were found concentrated within the first few fractions to be collected where they were clearly identifiable by the EBNA staining technique.
DISCUSSION
The results of the first group of experiments clearly demonstrate that EB virus-infected cells in vivo in acute IM blood are restricted to the B-lymphocyte population (Tables 2  and 3) , exactly as would be expected from in vitro studies which have shown that only B-lymphocytes have surface receptors for EB virus (Jondal & Klein, I973; Greaves, Brown & Rickinson, I974; Jondal et al. I976) .
The remaining experiments were designed to clarify the nature of the infection established by EB virus in vivo in the B-lymphocyte of IM patients. When EB virus infects B-lymphocytes in vitro, it induces cellular DNA synthesis (Gerber & Hoyer, I97I) and the appearance of large EBNA-positive blast cells transformed by the virus to be capable of unlimited proliferation (Leibold et al. I975; Moss & Pope, I975) . By analogy, therefore, it might be expected that the virus-infected cells in IM blood are present amongst the large atypical lymphocytes which are characteristic of this disease (Downey & McKinlay, I923; Finch, I969) and furthermore, that they are similarly transformed by the virus, potentially malignant but held in check by immunological surveillance (Klein, . Although many of the atypical lymphocytes in IM have been identified as T-cells (Sheldon et Holborow, 1974) and it is within this B-cell population that the presence of a few EBNApositive cells has recently been reported (Klein et al. 1976 ).
Occurrence of transformation in co-cultures between foetal mononuclear cells and fractions prepared on the basis of cell size from IM B-lymphocytes with monocytes
In the second group of experiments, the incidence of transformation in the co-cultures of foetal cells and B-lymphocytes with monocytes fractionated on the basis of cell size, provided a measure of the relative proportion of EB virus-infected cells in the different fractions. This must relate directly to the distribution of infected cells across the spectrum of cell size as it exists in IM blood, since the co-cultures were set up within 6 h of bleeding the patient, long before in vitro activation of infection and intercellular transfer of newly synthesized virus particles could have occurred (Rickinson, Epstein & Crawford, 1975) . Since transformation was seen most regularly in the co-cultures containing fractions I I to 14 (Table 4) , the majority of virus-infected cells in IM blood must reside in the population of normal sized B-lymphocytes. In some experiments foci of transformed cells appeared in co-cultures containing a broader range of fractions running from 7 to 17, and in one single case (IM patient 18, Table 4 ), transformation was seen in virtually all the co-cultures. This indicates that in certain patients at least, virus-infected cells can be detected amongst lymphoid cells of all sizes; it may be that such patients are at a clinically more acute stage of the disease with a relatively larger proportion of the circulating cells infected by the virus.
Of the EB virus-determined antigens detectable by fluorescent antibody techniques, EBNA is the only one consistently expressed in virus-transformed cells capable of direct outgrowth to give cell lines in vitro (Reedman & Klein, 1973) . Accordingly, in the final group of experiments EBNA-positive cells were sought in the total population of purified IM B-lymphocytes, and in fractions of this population prepared on the basis of cell size as well, in order to relate the incidence of EBNA-positive cells to the incidence of virus-infected cells. Because of the constraints on the amount of blood which could be taken from each patient and the limited numbers of B-lymphocytes obtainable from any o~,~ IM blood sample, the detection of virus-carrying cells and the EBNA testing had to be done on blood samples from separate groups of patients. However, the patients in the two groups were strictly comparable in terms of duration of symptoms and blood picture (Table I) .
The results of the EBNA tests call for comment. In our hands the EBNA staining technique was sufficiently sensitive to detect isolated EBNA-positive cells where these were present in populations at concentrations of between o. I and 1%. The failure to find EBNApositive cells amongst the B-lymphocytes from eight IM donors despite careful analysis of the preparations by three separate observers is of considerable significance because this result is at variance with that of Klein et al. (1976) . They reported that large EBNA-positive blast cells were present in the circulation of four out of seven acute IM patients examined, where they constituted o'5 to 2 ~o of the B-cell population. If this number of cells had been present in the blood of the eight patients used in the present work they would have appeared in the fractions of larger cells (fractions I to 8) where they would have been concentrated to an easily detectable level. It might be that the eight patients free of EBNA-positive cells studied here correspond to the three similar patients reported by Klein et al. (1976) and that the positive EBNA expression reported in four patients of the latter series merely denoted cells in the early stages of a productive infectious cycle.
In any event, it is clear from the present experiments that in IM the EB virus-infected cells in the circulation are B-lymphocytes (Tables 2 and 3) , mainly of normal size (Table 4) , which do not express EBNA in vivo, yet which give rise to cell lines when co-cultivated with foetal cells in vitro (Table 4 ). Chromosome analysis of the cell lines which appeared in the co-cultures showed that the two-step process of virus release followed by infection and transformation of co-resident cells took place on a large scale, since cell lines of foetal origin were either exclusively or predominantly present (Table 5 ). There can be no doubt that this virus was released following activation in vitro of a productive infection in cells which had been carrying the virus genome in a non-infectious form in vivo ; infectious virus cannot be detected either adsorbed to the surface or sequestered within leucocytes taken direct from the patient and is only manifest after the cells have been placed in culture for a few days (Rickinson, Epstein & Crawford, I975) .
The finding of the present work that the EB virus genome-containing cells in IM blood are EBNA-negative, and therefore seemingly not transformed by the virus, raises yet again the important question as to the real nature of their infection. On the one hand these cells may be able to persist in vivo harbouring the virus genome as a latent infection similar to that shown by other herpesviruses (Bastian et al. I972, I974; Baringer, I974) including now a lymphotropic member of the group-mouse cytomegalovirus (Olding, Kingsbury & Oldstone, I976) ; on the other hand these cells may all be in very early stages of the infectious cycle and about to be destroyed once they are recognized by the immune response. T-lymphocytes in IM blood are known to be mounting a specific cell-mediated response to cells bearing the EB virus-associated lymphocyte-detected membrane antigen, LYDMA (Royston et al. I975; Svedmyr & Jondal, I975; Rickinson, Crawford & Epstein, I977) , and it seems likely that LYDMA is expressed on at least some, if not all, of the virusinfected cells which can be found in the blood at this time. If this indeed proves to be the case, the present results showing these cells to be EBNA-negative would suggest that the expression of LYDMA precedes that of EBNA in the early stages of the infectious cycle.
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